Serum amyloid A (SAA) treatment enhances the recovery of aggravated 
polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results 
in early death

Linke, Reinhold P.; Meinel, Angelika; Chalcroft, James P.; Urieli-Shoval, Simcha

doi:10.1080/13506129.2017.1295950

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death

MPS-Authors

/persons/resource/persons77846

Chalcroft, James P.
MPI of Neurobiology, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Linke, R. P., Meinel, A., Chalcroft, J. P., & Urieli-Shoval, S. (2017). Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death. Amyloid-Journal of Protein Folding Disorders, 24(Suppl. 1), 149-150. doi:10.1080/13506129.2017.1295950.

引用: https://hdl.handle.net/11858/00-001M-0000-002D-BB0E-5

要旨

要旨はありません